abiraterone accord
accord healthcare s.l.u. - οξική απιρατερόνη - Νεοπλάσματα του προστάτη - Ενδοκρινική θεραπεία - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - οξική απιρατερόνη - Νεοπλάσματα του προστάτη - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
kestine® flash ling.tab 20mg/tab
galenica ΑΕ Ελευθερίας 4,, 145 64 145 64, Κηφισιά 210.5281700 - ebastine - ling.tab (ΕΠΙΓΛΩΣΣΙΟ ΔΙΣΚΙΟ) - 20mg/tab - ebastine 20mg - ebastine
xtandi
astellas pharma europe b.v. - ενζαλουταμίδιο - Νεοπλάσματα του προστάτη - Ενδοκρινική θεραπεία - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
abiraterone krka
krka, d.d., novo mesto - οξική απιρατερόνη - Νεοπλάσματα του προστάτη - Ενδοκρινική θεραπεία - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - Νεοπλάσματα Του Προστάτη, Ο Ευνουχισμός Ανθεκτικό - Θεραπευτικά ραδιοφαρμακευτικά προϊόντα - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
kestine flash ling.tab 10mg/tab
galenica ΑΕ Ελευθερίας 4,, 145 64 145 64, Κηφισιά 210.5281700 - ebastine - ling.tab (ΕΠΙΓΛΩΣΣΙΟ ΔΙΣΚΙΟ) - 10mg/tab - ebastine 10mg - ebastine
ilumetri
almirall s.a - tildrakizumab - Ψωρίαση - Ανοσοκατασταλτικά, αναστολείς Ιντερλευκίνης, - ilumetri ενδείκνυται για τη θεραπεία ενηλίκων με μέτρια έως σοβαρή ψωρίαση κατά πλάκας, που είναι υποψήφιοι για συστηματική θεραπεία.
nubeqa
bayer ag - darolutamide - Νεοπλάσματα Του Προστάτη, Ο Ευνουχισμός Ανθεκτικό - Ενδοκρινική θεραπεία - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - Πνευμονική Νόσος, Χρόνια Αποφρακτική - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - bretaris genuair ενδείκνυται ως συντήρηση θεραπεία με βρογχοδιασταλτικό για την ανακούφιση των συμπτωμάτων σε ενήλικες ασθενείς με χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ).